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Introduction
Studies indicate that sepsis and septic shock in resource-
limited settings are at least as common as in resource-
rich settings. The surviving sepsis campaign (SSC) 
guidelines have been widely adopted throughout the 
world, but in resource-limited settings are often unfea-
sible [1]. The guidelines are based almost exclusively on 
evidence from resource-rich settings and are not neces-
sarily applicable elsewhere due to differences in etiology 
and diagnostic or treatment capacity. An international 
team of physicians with extensive practical experience 
in resource-limited intensive care units (ICUs) identified 
key questions concerning the SSC’s infection manage-
ment recommendations, and evidence from resource-
limited settings regarding these was evaluated using the 
grading of recommendations assessment, development 
and evaluation (GRADE) tools. This article focuses pri-
marily on bacterial causes of sepsis and septic shock. 
Other infections common in resource-limited settings, 
such as malaria, are covered in a separate article in this 
series. Evidence quality was scored as high (grade A), 
moderate (B), low (C), or very low (D), and recommenda-
tions as strong (1) or weak (2). The major difference from 
the grading of recommendations in the SSC-guidelines 
was in taking account of contextual factors relevant to 
resource-limited settings, such as the availability, afford-
ability and feasibility of interventions in resource-limited 
ICUs. Strong recommendations have been worded as ‘we 
recommend’ and weak recommendations as ‘we suggest’ 
(details in online supplement).
Results and recommendations for management 
of infections in resource‑limited settings
There are important differences in the causative patho-
gens of sepsis and septic shock between resource-rich 
and resource-limited settings, as well as substantial vari-
ation between and within resource-limited settings. Hos-
pital, and especially ICU-related, infections are more 
likely to be caused by multidrug-resistant organisms and 
previous antibiotic use is a risk factor for antibiotic resist-
ance. Misdirected initial antibiotic therapy is associated 
with poor outcome [2, 3], but there is a paucity of epi-
demiological data in most low-resourced settings. We 
recommend empirical antibiotic therapy should cover 
all expected pathogens and likely resistance patterns 
(1C) based on locally-acquired epidemiological data as 
large regional variations exist (ungraded). We recognize 
that, in settings with a limited range of available antibi-
otics, this may be challenging. We suggest that research 
groups in collaboration with stakeholders provide micro-
biological data from sentinel sites throughout resource-
limited settings to guide local empirical antibiotic choices 
(ungraded).
There is weak evidence from resource-limited settings 
suggesting that timely administration of antibiotics is 
beneficial [2, 4–6]. Observational data suggest that, in 
many resource-limited settings, the administration of 
antibiotics to most patients within 1 h of sepsis or septic 
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shock recognition is feasible. Therefore, given biologi-
cal plausibility and evidence from resource-rich settings, 
we recommend appropriate antibiotics should be given 
within the first hour following sepsis or septic shock rec-
ognition (1C).
In resource-limited settings, microbiological labora-
tory facilities are often restricted, but there was evidence 
from these settings that taking blood cultures was associ-
ated with improved outcome in sepsis and septic shock 
and with improved appropriateness of antibiotics [2, 6, 
7]. No studies addressed incremental costs of implement-
ing microbiological capacity, or additional benefits of two 
sets of blood cultures. We recommend that blood cul-
tures should be taken before the administration of antibi-
otics in locations where this is possible (1B). Ideally, two 
sets of blood cultures should be obtained. It is realized 
that in many hospitals routine blood culture is unfeasi-
ble, but a recommendation of expanding microbiological 
laboratory capacity is beyond the scope of these recom-
mendations (Table 1).
Identification of an infection source and source control 
are additional challenges in resource-limited settings and 
are affected by the facilities available. There was weak evi-
dence of reasonable sensitivity of both chest radiography 
and ultrasound in the diagnosis of abdominal hollow vis-
cus perforation (mainly studied in typhoid or tuberculo-
sis) and abscesses in melioidosis [8–11]. We found weak 
evidence that timely surgery was beneficial in typhoidal 
gastro-intestinal perforations [5, 12]. We refrained from 
specific recommendations on use of chest radiography or 
ultrasound in resource-limited settings. We suggest that 
source control is carried out within 12 h of admission to 
hospital (ungraded), except in the specific case of pancre-
atic necrosis, where there is evidence from resource-rich 
settings that delay may be beneficial [1].
Combination antimicrobial therapy increases health-
care costs and toxicity. Current SSC-guidelines only rec-
ommend combination therapy in specific situations. such 
as when the chances of multidrug-resistance are high. 
Evidence in multidrug-resistant or extensively drug-
resistant bacteria was confined to studies of Acinetobac-
ter baumannii infection, where combination therapy 
was beneficial [3, 13]. Where the chances of multidrug 
resistance are high, combination antibiotics should be 
considered (2D). Choice of combination therapy should 
be guided by local epidemiology and known effective 
combinations (ungraded). Antimicrobial therapy should 
be de-escalated whenever possible (ungraded). We recog-
nize that without microbiological information de-escala-
tion is difficult.
In settings of limited microbiological capacity, 
semi-quantitative C-reactive protein or procalcitonin 
point-of-care tests are increasingly available and are a 
potential de-escalation tool. There was evidence that, 
even in resource-limited settings, procalcitonin-guided 
antibiotic policies are cost-effective, with test costs off-
set by antibiotic savings. Two studies showed benefit of 
procalcitonin guidance on de-escalation in sepsis and 
septic shock [14, 15]. Nevertheless, in view of reduced 
microbiological capacity and higher antimicrobial 
resistance levels, we believe the use of biomarkers for 
de-escalation of antimicrobial therapy needs further 
study in resource-limited settings before a recommen-
dation can be made.
Table 1 Recommendations and  suggestions on  infection control in  patients with  sepsis or septic shock in  in resource‑
limited settings
1 Choice of empiric therapy As poor outcome is associated with inappropriate antibiotic therapy, empirical therapy should aim to cover all expected 
pathogens and likely resistance patterns (1C). We suggested that research groups in close collaboration with stake-
holders provide microbiological data from sentinel sites throughout LMICs to guide empirical antibiotic treatment 
(ungraded)
2 Timing of antibiotics We recommend that appropriate antibiotics should be given within the first hour in severe sepsis and septic shock (1C)
3 Taking blood cultures We recommend that blood cultures should be taken before the administration of antibiotics (1B). It is realized that in 
many hospitals in resource-limited countries routine blood culture in sepsis is not feasible
4 Source control We suggest source control is carried out within 12 h of admission to hospital except in the specific case of pancreatic 
necrosis (ungraded). Radiography and ultrasound are good first line imaging techniques. If an intravascular device is 
suspected this should be removed (ungraded)
5 Combination antibiotics Where the possibility of multi-drug resistant micro-organisms is high, we suggest that combination antibiotics should 
be used (2D). In settings with facilities for blood culture and antibiotic resistance testing, antimicrobial therapy should 
be de-escalated when culture results are available (ungraded).We suggest that choice of combination therapy should 
be guided by local epidemiology and known effective combinations (ungraded)
6 Biomarkers Use of biomarkers like procalcitonin and C-reactive protein for de-escalation of antimicrobial therapy needs further 
study in resource-limited settings before a recommendation can be made
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Conclusion
Large variations in disease etiology and high rates of 
antimicrobial resistance combined with restricted choice 
of antibiotics and limited microbiological data pose sig-
nificant challenges in the management of septic patients 
in resource-limited settings. Increased use of combi-
nation therapy and broad spectrum antibiotics risks 
increasing antimicrobial resistance. Enhanced surveil-
lance necessitates better collaboration between stake-
holders and improved microbiological facilities, which 
in turn requires significant investment. However, newer 
technologies which negate the need for specialist staff 
and equipment may become more available. This would 
not only improve the management of individual patients 
but, by providing high-quality epidemiological data, may 
help combat the global threat of antimicrobial resistance.
Electronic supplementary material
The online version of this article (doi:10.1007/s00134-016-4415-3) contains 
supplementary material, which is available to authorized users.
Author details
1 Oxford University Clinical Research Unit, Hospital for Tropical Diseases, 764 
Vo Van Kiet, Ho Chi Minh City, Vietnam. 2 Oxford Centre for Tropical Medi-
cine and Global Health, Nuffield Department of Clinical Medicine, Oxford, 
UK. 3 Department of Critical Care Medicine, Mongolian National University 
of Medical Sciences, Ulaanbaatar, Mongolia. 4 Mahidol-Oxford Tropical Medi-
cine Research Unit (MORU), Faculty of Tropical Medicine, Mahidol University, 
Bangkok, Thailand. 5 Department of Intensive Care, Academic Medical Center, 
University of Amsterdam, Amsterdam, The Netherlands. 
Acknowledgments
Infection control subgroup members: Neill KJ Adhikari (Sunnybrook Health 
Sciences Centre and University of Toronto, Toronto, ON, Canada), Jane Nak-
ibuuka (Mulago National Referral and University Teaching Hospital, Kampala, 
Uganda), Randeep Jawa (Stony Brook University Medical Center, Stony Brook, 
NY, USA), Mervyn Mer (Johannesburg Hospital and University of the Witwa-
tersrand, Johannesburg, South Africa), Srinivas Murthy (BC Children’s Hospital, 
University of British Columbia, Vancouver, Canada), Marcus Schultz (Academic 
Medical Center, University of Amsterdam, Amsterdam, The Netherlands and 
Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand), Binh 
Nguyen Thien (Trung Vuong Hospital, Ho Chi Minh City, Vietnam), Arthur 
Kwizera (Mulago National Referral Hospital, Kampala, Uganda).
Open Access This article is distributed under the terms of the Creative 
Commons Attribution-NonCommercial 4.0 International License (http://
creativecommons.org/licenses/by-nc/4.0/), which permits any noncommer-
cial use, distribution, and reproduction in any medium, provided you give 
appropriate credit to the original author(s) and the source, provide a link to 
the Creative Commons license, and indicate if changes were made.  
Received: 2 May 2016   Accepted: 1 June 2016
Published online: 21 June 2016
References
 1. Dellinger RP, Levy MM, Rhodes A et al (2013) Surviving sepsis campaign: 
international guidelines for management of severe sepsis and septic 
shock: 2012. Crit Care Med 41:580–637
 2. Yokota PKO, Marra AR, Martino MDV et al (2014) Impact of appropriate 
antimicrobial therapy for patients with severe sepsis and septic shock—a 
quality improvement study. PLoS ONE 9:e104475
 3. Santimaleeworagun W, Wongpoowarak P, Chayakul P et al (2011) Clinical 
outcomes of patients infected with carbapenem-resistant Acinetobacter 
baumannii treated with single or combination antibiotic therapy. J Med 
Assoc Thail 94:863–870
 4. Jalili M, Barzegari H, Pourtabatabaei N et al (2013) Effect of door-to-antibi-
otic time on mortality of patients with sepsis in emergency department: 
a prospective cohort study. Acta Med Iran 51:454–460
 5. Chalya PL, Mabula JB, Koy M et al (2012) Typhoid intestinal perforations at 
a university teaching hospital in Northwestern Tanzania: a surgical experi-
ence of 104 cases in a resource-limited setting. World J Emerg Surg 7:4
 6. Phua J, Koh Y, Du B et al (2011) Management of severe sepsis in patients 
admitted to Asian intensive care units: prospective cohort study. BMJ 
342:d3245
 7. Guo Q, Li H-Y, Li Y-M et al (2014) Compliance with severe sepsis bundles 
and its effect on patient outcomes of severe community-acquired pneu-
monia in a limited resources country. Arch Med Sci 10:970–978
 8. Ansari AG, Qaiser S, Naqvi H et al (2009) Management oftyphoid ilial 
perforation: a surgical experience of 44 cases. Gomal J Med Sci 7:27–28
 9. Patil V, Vijayakumar A, Ajitha MB, Kumar LS (2012) Comparison between 
tube ileostomy and loop ileostomy as a diversion procedure. ISRN Surg 
2012:547523
 10. Morse LP, Moller C-CB, Harvey E et al (2009) Prostatic abscess due to Bur-
kholderia pseudomallei: 81 cases from a 19-year prospective melioidosis 
study. J Urol 182:542–547
 11. Maude R, Teerapon I, Ariyaprasert P et al (2012) Prospective observational 
study of the frequency and features of intra-abdominal abscesses in 
patients with melioidosis in northeast Thailand. Trans R Soc Trop Med 
Hyg 106:629–631
 12. Khanna A, Misra MK (1984) Typhoid perforation of the gut. Postgrad Med 
J 60:523–525
 13. Batirel A, Balkan II, Karabay O et al (2014) Comparison of colistin–carbap-
enem, colistin–sulbactam, and colistin plus other antibacterial agents 
for the treatment of extremely drug-resistant Acinetobacter baumannii 
bloodstream infections. Eur J Clin Microbiol Infect Dis 33:1311–1322
 14. Deliberato RO, Marra AR, Sanches PR et al (2013) Clinical and economic 
impact of procalcitonin to shorten antimicrobial therapy in septic 
patients with proven bacterial infection in an intensive care setting. 
Diagn Microbiol Infect Dis 76:266–271
 15. Qu R, Ji Y, Ling Y et al (2012) Procalcitonin is a good tool to guide therapy 
in patients with severe acute pancreatitis. Saudi Med J 33:382–387
